Siyu Shi is an Associate at F-Prime Capital and works across the healthcare sub-sectors including Therapeutics, MedTech, and Healthcare IT and Services, and also closely with the Eight Roads Ventures China team to manage F-Prime’s existing and new investment efforts in China. Prior to joining F-Prime Capital, Siyu consulted for biotech start-ups and investment funds.

Siyu’s research focused on artificial intelligence and data science in healthcare at the Stanford Machine Learning Group, including projects in rare disease detection in imaging, self-supervised learning with sound data, transformer model for heart attack prediction, causal inference for heterogenous treatment effects, and oncology outcome research. Previously, she also worked on biomaterials and peptide chemistry at Rice University and MIT.

Siyu holds an MD and a MS in Epidemiology from Stanford School of Medicine, as well as an MBA from Stanford Graduate School of Business.